|
|
The 23rd Pharmaceutical & Medical Device Ethics and Compliance Congress Features Behavioral Compliance: Overview and Application for Pharma and Medical Device Ethics and Compliance Leaders
|
- A Hybrid Onsite Conference and Internet Event
- Sponsored by Pharmaceutical Compliance Forum
- Media Partners: Policy & Medicine Compliance Update
- October 24-26, 2022
- Capitol Hyatt, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
|
NEWLY CONFIRMED KEYNOTE SPEAKER
|
Sally Molloy, JD
Deputy Chief, Fraud Section, US Department of Justice, Washington, DC
|
|
|
|
AND FEATURING BEHAVIORAL COMPLIANCE: OVERVIEW AND APPLICATION FOR PHARMA AND MEDICAL DEVICE ETHICS AND COMPLIANCE LEADERS
|
|
Behavioral compliance is the design and management of compliance programs that draw from behavioral predictions about individual and organizational behavior. In this two-part workshop, behavioral compliance expert Prof. Todd Haugh breaks down how the tools of behavioral science can be harnessed in ethics and compliance. In Part I, participants will learn research-based behavioral theory and how to apply it in their organizations. In Part II, participants will hear from a panel of senior compliance leaders whose companies are at differing stages of their behavioral compliance journey. Panelists will share how behavioral science is currently being used in their companies, best practices, and pitfalls. Participants will leave inspired to use behavioral compliance tools to improve their own E&C programs and with actionable steps to make it a reality.
|
Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly |
Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb |
Kirsten Mayer, JD
Former Head of US Compliance, Vice President Legal, Argenx |
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University (Moderator)
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- OCTOBER 12, 2022: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Third Pharmaceutical & Medical Device Ethics and Compliance Congress is returning to the Hyatt Regency on Capitol Hill in Washington, DC on October 24-26, 2022.
|
|
KEYNOTE SPEAKERS
|
Charlene Keller Fullmer, JD
Assistant United States Attorney; Deputy Chief, Affirmative Litigation; US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA |
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD |
Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK
|
Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA |
Glenn Leon, JD
Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard Enterprise (HPE), Washington, DC |
Sally Molloy, JD
Deputy Chief, Fraud Section, US Department of Justice, Washington, DC
|
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC |
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC |
Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
|
|
|
AND FEATURING
|
- We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
- Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
- An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25
For more information contact pcf.org.info@gmail.com.
- Annual reports and updates provided by DOJ, FDA, and OIG
- Over 30 current topics addressing crucial ethics, compliance and legal issues
- An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26
|
|
FEATURED FACULTY
|
Khelin N. Aiken, JD
Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA |
Punkaj T. Amin, MBA, CFE
Compliance Officer, Global Wound Management, Smith & Nephew |
Madelyn Archibald
Compliance Specialist, Bioventus
|
Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP |
Kristiana Bankova, MS
Senior Manager, Forensics & Integrity Services, EY |
Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire
|
Rachel Batykefer
Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt |
Ann E. Beasley, JD
Vice President and Chief Compliance Officer, Zai Lab |
Allison Benkert, MBA
Director Global Compliance Investigations, Seagen
|
Haskell Berman
Senior Vice President, State Affairs at HealthCare Institute of NJ |
Joshua Blank, JD
Senior Attorney, Arnold & Porter |
Eric Bolesh
Chief Operating Officer, Cutting Edge Information
|
Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx Pharmaceutical |
Keysha Bradford
Director of Compliance, Amplity Health |
Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California
|
Eve M. Brunts, LLM, JD
Partner, Ropes & Gray |
Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems; Vice President Compliance, Mesoblast |
Tim Canonico
Principal, Pharmaceutical & Life Sciences, Risk & Regulatory Leader, PwC
|
Susy Cardoso, JD, LLM
Former Executive Director of Ethics & Compliance, Amarin |
Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey |
Cynthia Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior
|
Cheryl Chamallas
Sr. Director, Global Compliance Risk, argenx |
Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme |
Shoshanna Clark, JD
Head of USBU Ethics & Compliance Operations, Takeda
|
Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly |
Chris Corallo
Compliance Officer, North America, Convatec |
Zachary Coseglia, JD
Managing Principal & Head of Innovation, R&G Insights Lab, Ropes & Gray
|
Clarissa Crain
Managing Director, Deloitte & Touche LLP |
David W. Cromley, JD
Associate Vice President, Global Compliance Organization, Merck |
Tiffany Cummings-Damiani, MBA
Vice President and Head of Global Compliance, Insmed Incorporated
|
Donna Daniels, JD
Managing Director, Forensic & Integrity Services, EY |
Mahnu V. Davar, MA, JD
Partner, Arnold & Porter |
BJ D'Avella, MBA
Life Sciences Consulting Group Leader, Paul Hastings
|
James M. Dawson
Vice President, Compliance Solutions, Qordata |
Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences |
Chris DePhillips, JD
Senior Vice President, Chief Operating Officer and General Counsel, Porzio Life Sciences
|
Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP |
Avia M. Dunn, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP |
Gildas Durand
Principal, Forensic & Integrity Services, EY
|
David Falcone
Associate Vice President Global Compliance, Merz Aesthetics |
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC |
Nicole L. Felician, JD
Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US
|
Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Chief Compliance Officer, Purdue Pharma LP |
Kellie Fidler, MBA, PMP
Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb |
Melissa Fitzgerald, JD
Privacy Officer, Olympus Corporation of the Americas
|
Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis |
Sara Frank, JD
Principal, Choate, Hall & Stewart LLP |
Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Litigation and Investigations Practice Group, Covington & Burling LLP
|
Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb |
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda |
Gary F. Giampetruzzi, JD
Partner, Paul Hastings
|
Tara K. Giunta, JD
Partner, Paul Hastings |
Edward P. Glynn, MBA
Principal, EY |
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ
|
Tom Gregory, MBA, CPA
Partner, Forensic & Integrity Services, EY |
Noor Haq, MBA, MS, CCEP
Executive Director, US Compliance, Amgen |
Beth Hardcastle, JD
Partner, Sidley Austin LLP
|
Judith Haron, JD
Assistant General Counsel, PhRMA; Former Acting Chief Counsel, HHS |
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University |
Saul B. Helman MD, MBA
President, Epsilon Life Sciences
|
Kevin Henley, JD
Vice President, US Chief Compliance Officer, Otsuka America Pharmaceutical, Inc |
Michael Hercz, JD
Senior Vice President & General Counsel, Sentynl |
Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP
|
Denis Jacob
Managing Director, Risk & Regulatory, PwC |
Brenna E. Jenny, JD
Partner, Sidley |
Abe Kassis, MBA, PhD
Senior Director, Global Head of Compliance and Legal Operations, Bausch + Lomb
|
Jeffrey Kawalek, MBA
Deputy, Chief Compliance Officer, Jazz Pharmaceuticals |
Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma |
Daniel Koerner
Senior Director, Potomac River Partners
|
Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna |
JJ Kuhn, JD
Vice President, Chief Counsel, Global Investigations, Medtronic |
Stephanie Kurteff, JD, HCCP
Head of Compliance, Healthcare Compliance Officer, Medicines360
|
Rebekah Latchis, JD
Senior Director, Americas Office of Ethics and Compliance, Medtronic |
Rachel Lei, JD
Vice President and General Counsel, Aldevron |
Kirsten Liston
Principal and Founder, Rethink Compliance
|
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ |
Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding |
Kevin J. Ma, JD
US Head of Compliance & Managing Counsel, PharmaEssentia USA
|
Jason Macias, JD
Head of Risk Assessment, Monitoring, Transparency, Global Trade, and Medical Affairs Compliance, Viatris |
Jim Massey, MS
Chief Sustainability Officer, Zai Lab |
Chris C. Matteson
Senior Manager, Forensic & Integrity Services, EY
|
Kirsten Mayer, JD
Former Head of US Compliance, Vice President Legal, Argenx |
Dana S. McMahon, JD
Vice President, Global Chief Compliance Officer, Stryker |
Rore Middleton, JD
Vice President, Compliance and Ethics at Blueprint Medicines, Member of Chief
|
David Mortlock, JD
Managing Partner, Global Trade & Investment Group, Willkie Farr & Gallagher LLP |
Gregory S. Moss, JD
Chief Corporate Strategy and Legal Officer, Evommune |
Lucy Muzzy, JD
Vice President, Compliance - M&A/Business Development, Government Agreements, Digital Health & Artificial Intelligence, Pfizer
|
Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California |
Katherine Norris, MPA
Managing Director, Epsilon Life Sciences |
Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals
|
Daniel O'Connor
Senior Vice President, PharmaCertify |
Jackie Parris
Director, Compliance, Incyte Corporation |
Chelsea Ott, JD
Director, Global Regulatory, MedPro Systems
|
Mohammad Ovais
Chief Executive Officer, Qordata & Veraqor |
Amy Pawloski, CCEP
President, Strategic Versatility |
Veleka R. Peeples-Dyer, JD
Chief Legal Officer and Chief Compliance Officer, Opentrons Labworks
|
Danielle Pelot, JD
Partner, Choate, Hall & Stewart LLP |
Joseph Philipose, JD
Senior Vice President, Chief Compliance Officer, Emergent Biosolutions |
Zoe Philippides, JD
Senior Vice President, Chief Ethics, Compliance & Privacy Officer, Moderna
|
Susan Pietras
Global Project Lead - Training, Communication and Policies, Sanofi |
Lawrence P. Platkin, JD
Vice President and Head, U.S. Office of Compliance, Bayer US |
Cory Potomis, MS
Director, Ethics & Compliance Strategy & Operations, Novo Nordisk, Plainsboro, NJ
|
Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding |
Jennifer A. Romanski, JD
Senior Vice President, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC |
Howard Root, JD
Chairman, Reprise Biomedical; Former, CEO & Co-Founder, Vascular Solutions
|
Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group |
David Ryan, JD
Vice President and Chief Compliance Officer, Epizyme |
Nashmil Sadjadi
Associate Director Compliance Operations, Exelixis
|
Monica Schroeter, CPA, CISA
Senior Director, Compliance & Privacy , SK Life Science |
Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS |
Tara Shewchuk, JD, LLM
Global Chief Ethics and Compliance Officer, Medtronic
|
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory |
Ed Sleeper, MS
Ethics & Compliance Officer (U.S. & Europe), HUTCHMED |
Tim Slone, MS, HCCP
Vice President, Global Compliance, Novavax
|
Damon Strickland
Associate Vice President, Ethics & Compliance Global Operational Capabilities, Eli Lilly |
Kaarthick Subramanian, MBA
Chief Compliance Officer, Atlas Systems |
Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP
|
Bryan Timer, MBA
Director, Global Compliance, Data Analytics and Transparency COE, Merck |
Kelly J. Tope, JD, MBA
Head of USBU Monitoring and Reporting Operations, Takeda |
Annalisa Torrente
Director, Medical Governance & Operations, POINT Biopharma
|
Manny Tzavlakis
Managing Partner, Helio Health Group; Chief Executive Officer, Helio Argos |
Beth P. Weinman, JD
Counsel, Ropes & Gray; Former Associate Chief Counsel, FDA |
Caroline West, JD
Principal, Loganbrook Advisory LLC; Former SVP Global CCO, Olympus
|
Amy Wilson, MBA, MSJ
Vice President and Chief Compliance Officer, Esperion Therapeutics |
Ronald L. Wisor, Jr, JD
Partner, Hogan Lovells |
Olga Zinavenka, CPA, MBA
Senior Director, Compliance Investigations, Endo International
|
|
|
AGENDA NOW AVAILABLE
|
Click Here for Agenda.
|
|
SPONSORED BY
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 100+ distinguished researched-based pharmaceutical manufacturers and biotech companies.
|
|
PRODUCED BY
|
|
|
PCF EXECUTIVE COMMITTEE
|
Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair)
Christie Camelio
Chief Compliance and Risk Officer, EQRx
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte
Joshua M. Marks, JD
Global Head of E&C Program and Governance, Takeda Pharmaceuticals
Margaret Sparks, JD
Head of Compliance, Vaccines & North America Ethics and Business Integrity, Sanofi
Donna White, CCEP
Vice President, Compliance Office, Chiesi
|
|
MEDICAL DEVICE EXECUTIVE STEERING COMMITTEE
|
Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.
Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
GRANTORS
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITORS:
|
|
|
MEDIA PARTNERS:
|
|
|
CONTINUING EDUCATION:
|
COMPLIANCE CERTIFICATION BOARD CONTINUING EDUCATION UNITS (CCB CEUs)
The Congress is pending approval for Compliance Certification Board (CCB)® Continuing Education Units.
CONTINUING LEGAL EDUCATION
The Pharmaceutical and Medical Device Ethics and Compliance Congress has been approved to offer 15.25 Pennsylvania CLE Credits. To qualify for CLE credits, you must (1) pay $100 ands (2) complete and submit the Pharma Congress Continuing Education Credit Self Reporting and Evaluation Form.
Click here for details.
CERTIFICATE OF ATTENDANCE
Attendees can click here to request a Certificate of Attendance on which they can certify the number of hours they watched and can file with appropriate entities for credit.
|
|
TUITION SCHOLARSHIPS:
|
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.
Click here for more information.
|
|
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
|
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
| |
